» Articles » PMID: 7969970

Longitudinal MRI in Multiple Sclerosis: Correlation Between Disability and Lesion Burden

Overview
Journal Neurology
Specialty Neurology
Date 1994 Nov 1
PMID 7969970
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

We followed 18 multiple sclerosis patients clinically and with repeated brain MRIs with and without gadolinium for over 1 year. Clinical evaluations included scoring on the Kurtzke Expanded Disability Status Scale (EDSS) and the Ambulation Index (AI) scale. There was a significant correlation between the change in EDSS or AI and the change in number of lesions on MRI and between cumulative number of lesions on MRI and cumulative change in EDSS or AI. Our findings support the validity of MRI as a measure of clinical activity and potentially as an objective quantitative outcome measure for assessing response to therapy.

Citing Articles

Predictive MRI Biomarkers in MS-A Critical Review.

Tiu V, Enache I, Panea C, Tiu C, Popescu B Medicina (Kaunas). 2022; 58(3).

PMID: 35334554 PMC: 8949449. DOI: 10.3390/medicina58030377.


CNS endothelial derived extracellular vesicles are biomarkers of active disease in multiple sclerosis.

Mazzucco M, Mannheim W, Shetty S, Linden J Fluids Barriers CNS. 2022; 19(1):13.

PMID: 35135557 PMC: 8822708. DOI: 10.1186/s12987-021-00299-4.


Biomarkers in Multiple Sclerosis.

Paul A, Comabella M, Gandhi R Cold Spring Harb Perspect Med. 2018; 9(3).

PMID: 29500303 PMC: 6396336. DOI: 10.1101/cshperspect.a029058.


An Automated Statistical Technique for Counting Distinct Multiple Sclerosis Lesions.

Dworkin J, Linn K, Oguz I, Fleishman G, Bakshi R, Nair G AJNR Am J Neuroradiol. 2018; 39(4):626-633.

PMID: 29472300 PMC: 5895493. DOI: 10.3174/ajnr.A5556.


Multiple sclerosis: genetics, biomarkers, treatments.

Axisa P, Hafler D Curr Opin Neurol. 2016; 29(3):345-53.

PMID: 27058221 PMC: 7882195. DOI: 10.1097/WCO.0000000000000319.